Breaking News Instant updates and real-time market news.

TM

Toyota

$122.36

1.05 (0.87%)

, VLKAY

Volkswagen

$0.00

(0.00%)

07:11
01/09/19
01/09
07:11
01/09/19
07:11

China 2018 car sales down for the first time in over 20 years, Bloomberg says

According to data from China Passenger Car Association, sales of autos in China during 2018 fell 6% to 22.7M cars and marked the first decline in over 20 years, Bloomberg reports. The report attributes the decline to weakening investor sentiment and the impact of the trade war. Publicly traded companies in the space include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM) and Volkswagen (VLKAY). Reference Link

TM

Toyota

$122.36

1.05 (0.87%)

VLKAY

Volkswagen

$0.00

(0.00%)

F

Ford

$8.36

0.07 (0.84%)

HMC

Honda

$28.48

0.66 (2.37%)

GM

General Motors

$34.81

0.45 (1.31%)

NSANY

Nissan

$0.00

(0.00%)

FCAU

Fiat Chrysler

$15.34

0.16 (1.05%)

DDAIF

Daimler AG

$0.00

(0.00%)

  • 11

    Jan

  • 15

    Jan

  • 15

    Jan

  • 23

    Jan

  • 06

    Feb

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

TM Toyota
$122.36

1.05 (0.87%)

12/06/18
JEFF
12/06/18
UPGRADE
JEFF
Buy
Toyota upgraded to Buy from Hold at Jefferies
Jefferies analyst Takaki Nakanishi upgraded Toyota Motor to Buy.
06/06/18
MSCO
06/06/18
NO CHANGE
MSCO
Morgan Stanley says Softbank stake in Cruise significant 'far beyond' just GM
Morgan Stanley analyst Adam Jonas said Softbank's (SFTBF) recently announced investment in GM Cruise "carries significance far beyond" General Motors (GM), arguing that the increasingly conspicuous involvement of "outside validators" such as large-cap tech firms and prominent investors can accelerate perception change in the capital markets about "Auto 2.0." He envisions the possible formation of two different companies currently held under one automaker's roof, which he dubs an Auto 2.0 "Yieldco" and an Auto 2.0 "Growthco." Converting car owners into monthly subscribers could open up significant revenue, profit, and value opportunities for traditional automakers, argues Jonas in a note to investors. Other automaking "OEMs" include Ford (F), Daimler (DDAIF), Toyota (TM), Honda (HMC), Fiat Chrysler (FCAU) and BMW Group (BAMXY).
10/22/18
BOFA
10/22/18
UPGRADE
BOFA
Buy
Toyota upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Kei Nihonyanagi upgraded Toyota to Buy from Neutral and raised estimates saying Q2 results confirm progress in improving North American profits and the share buyback announcement supports the share price.
11/19/18
JPMS
11/19/18
UPGRADE
JPMS
Overweight
Toyota upgraded to Overweight from Neutral at JPMorgan
VLKAY Volkswagen
$0.00

(0.00%)

09/19/18
VERF
09/19/18
NO CHANGE
VERF
Sell
E-tron may not be 'Tesla killer,' but still a 'real risk,' says Vertical Group
After attending Audi's (AUDVF) launch event for its e-tron SUV, Vertical Group analyst Gordon Johnson said he sees Audi's foray in the EV space as "a real risk" to Tesla (TSLA) and other EV auto makers including Chevy (GM) and Ford (F). The Electrify America charging network, owned by a JV of Audi parent Volkswagen (VLKAY) and funded by "Dieselgate," positions Audi's fast-charging ambitions among the most robust, if not the most robust, in the U.S. currently, added Johnson. He does not see Audi's forthcoming e-tron as a "TSLA Killer," but does not "see it a stretch to think of it as a potential TSLA Model X killer," he concludes in his note to investors. Johnson keeps a Sell rating on Tesla shares.
06/15/18
JEFF
06/15/18
NO CHANGE
Target $53
JEFF
Buy
As VW appointment drives Navistar speculation, Jefferies sees eventual buyout
Noting that Navistar (NAV) shares are rising amid broader market weakness today following a Reuters report that Volkswagen (VLKAY) has appointed a new CFO noted to be an M&A expert, Jefferies analyst Stephen Volkmann said he continues to believe Volkswagen will pursue full ownership of Navistar, although he calls the timing of such an event "highly uncertain." He maintains a Buy rating and "Street high" price target of $53 on Navistar shares.
11/27/18
MSCO
11/27/18
NO CHANGE
MSCO
Equal Weight
Ford's biggest challenges must be confronted alone, says Morgan Stanley
Morgan Stanley analyst Adam Jonas said Ford (F) shares have been moving on hopes of significant cooperation with Volkswagen (VLKAY) following the signing of an MOU between the two automakers last June. While he believes VW and Ford have some "extremely complementary areas of weakness and strength" and he sees scope for a VW collaboration to save Ford $2B-$4B annually or more, Jonas also contends that Ford's "biggest challenges must be confronted alone." He added that a full merger or "grand alliance" is a long shot and Jonas does not expect a significant flow of capital from Ford to VW or vice versa at this stage. He maintains an Equal Weight rating on Ford shares, stating that General Motors' (GM) restructuring announcement will focus investor attention on Ford's next steps.
12/04/18
JEFF
12/04/18
NO CHANGE
Target $53
JEFF
Buy
Navistar defense unit sale removes takeover hurdle, says Jefferies
Jefferies analyst Stephen Volkmann believes the sale of Navistar International's (NAV) defense business to Cerberus "clears a potential hurdle" for the truck business to be sold to foreign entity Traton. The analyst says he's long noted his expectation that Navistar will ultimately be sold to Traton, the Volkswagen (VLKAY) Truck & Bus businesses that is on track for initial public offering in Q1 of 2019. Given that foreign acquisitions of U.S. defense businesses are "inherently problematic," Volkmann views yesterday's unit sale as "removing an important potential hurdle." He keeps a Buy rating on Navistar with a $53 price target.
F Ford
$8.36

0.07 (0.84%)

12/18/18
MSCO
12/18/18
NO CHANGE
Target $10
MSCO
Equal Weight
Ford potential dividend cut could be a buy signal, says Morgan Stanley
Morgan Stanley analyst Adam Jonas said he continues to expect Ford to cut its dividend in half during 2019, but such a potential cut of the dividend could be a buy signal in his view. Such a cut would be a sign that Ford is prepared to make a stronger commitment to sustainable technology than he believes has been demonstrated thus far, Jonas explained. The analyst, who thinks Ford's decisions in the next 6 months could set the tone for the stock over the next several years, also forecasts Ford will undertake a "very significant" restructuring over the next 12 to 18 months that could reduce the size of the company's footprint by more than 25% and include as much as 25,000 headcount cuts. Jonas maintains an Equal Weight rating and $10 price target on Ford shares.
12/14/18
12/14/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Outperform at Wedbush and a Hold at Deutsche Bank. 2. New York Times (NYT) initiated with an Outperform at Evercore ISI. 3. Ford (F) and General Motors (GM) were initiated with a Buy at Deutsche Bank, while Autoliv (ALV) was initiated with a Sell. 4. AstraZeneca (AZN) initiated with a Buy at SunTrust while GlaxoSmithKline (GSK) was initiated with a Hold. 5. DaVita (DVA) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/13/18
DBAB
12/13/18
INITIATION
DBAB
Deutsche Bank initiates auto sector with cautious view
Deutsche Bank analyst Emmanuel Rosner initiated coverage of the auto sector with a cautious view. Rosner said this view reflects "cyclical and macro risks for the industry across the globe, as well as secular pressure from the shift towards electrified vehicles and autonomous shared mobility." The analyst favors suppliers with "secular growth potential through adoption of their technology," and as such, initiated Aptiv (APTV) and BorgWarner (BWA) with Buy ratings. Rosner also saw value in "suppliers that can maintain organic growth through share gains or favorable end-markets, and have favorable operational track record," and as such, initiated Dana Inc (DAN) and Lear Corporation (LEA) with Buy ratings. The analyst also started General Motors (GM) and Ford (F) with Buy ratings, citing "large potential upside from restructuring and portfolio decisions, favorable product mix and cycle, and value optionality from their efforts in Mobility." Rosner said he was negative on stocks facing secular pressure or market share loss, adding that he sees downside risk in Autoliv (ALV) and Veoneer (VNE), which he initiated with Sell ratings.
12/13/18
DBAB
12/13/18
INITIATION
Target $12
DBAB
Buy
Ford initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Emmanuel Rosner started Ford Motor with a Buy rating and $12 price target.
HMC Honda
$28.48

0.66 (2.37%)

10/03/18
LYON
10/03/18
DOWNGRADE
LYON
Outperform
Honda downgraded to Outperform from Buy at CLSA
10/03/18
10/03/18
DOWNGRADE

Outperform
Honda downgraded to Outperform on signs of lower demand at CLSA
As previously reported, CLSA analyst Christopher Richter downgraded Honda to Outperform from Buy and lowered his estimates given signs he sees that demand for its vehicles appears to be levelling out in North America, China and Japan. The analyst, who still sees Honda "easily beating" its fiscal year guidance, but not by as much as before, lowered his price target on Honda shares to Y3,900 from Y4,200.
10/03/18
10/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Hold from Buy at HSBC with analyst Erwan Rambourg saying while the company's Q1 results were strong and the outlook "remains rock solid," the company's valuation multiple of 30-times forward earnings may weigh on the stock. 2. Oracle (ORCL) downgraded to In Line from Outperform at Evercore ISI with analyst Kirk Materne saying even though growth is expected to accelerate modestly in the second half of this year, there are not enough catalysts for share to "meaningfully re-rate" from current levels, adding that the risk-reward appears balanced following this summer's rally. 3. Honda (HMC) downgraded to Outperform from Buy at CLSA with analyst Christopher Richter saying demand for its vehicles appears to be leveling out in North America, China and Japan. 4. Asbury Automotive (ABG) downgraded to Neutral from Buy at Buckingham. 5. Hi-Crush Partners (HCLP) downgraded to Hold from Accumulate at Johnson Rice and to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/18
LYON
10/30/18
UPGRADE
LYON
Buy
Honda upgraded to Buy from Outperform at CLSA
GM General Motors
$34.81

0.45 (1.31%)

01/07/19
01/07/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Outperform from Market Perform at BMO Capital with analyst Richard Carlson citing a "brighter spotlight" being placed on the GM Cruise model in 2019 leading to more appropriate value being priced into the shares. 2. Alphabet (GOOG, GOOGL), Adobe (ADBE), and Salesforce (CRM) were upgraded to Buy from Hold at Pivotal Research. 3. Citi (C) upgraded to Outperform from Neutral at Macquarie with analyst David Konrad saying despite macro uncertainties, he sees Citi's stock as compelling due to his expectations for improving performance, continued operating leverage and credit risk concerns that he views as overdone. 4. Micron (MU) upgraded to Outperform from Market Perform at BMO Capital with analyst Ambrish Srivastava citing valuation. 5. Dillard's (DDS) upgraded to Neutral from Underweight at JPMorgan with analyst Matthew Boss saying he sees a more balanced risk/reward with the stock underperforming the over the past few years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/07/19
BMOC
01/07/19
UPGRADE
Target $41
BMOC
Outperform
General Motors upgraded to Outperform at BMO Capital on Cruise potential
As reported earlier, BMO Capital analyst Richard Carlson upgraded General Motors to Outperform from Market Perform and also raised his price target to $41 from $38. The analyst cites a "brighter spotlight" being placed on the GM Cruise model in 2019 leading to more appropriate value being priced into the shares. Carlson also believes that General Motors' restructuring measures will yield improved profitability and higher free cash flows while also generating "cyclical resilience" for the stock that should generate a higher multiple.
01/07/19
BMOC
01/07/19
UPGRADE
BMOC
Outperform
General Motors upgraded to Outperform from Market Perform at BMO Capital
NSANY Nissan
$0.00

(0.00%)

03/13/18
MSCO
03/13/18
NO CHANGE
MSCO
Morgan Stanley compares automakers to Facebook, Apple in 'Auto 2.0' model
Morgan Stanley analyst Adam Jonas noted that auto companies' valuations have compressed to extremely low levels, but he believes that a move from a vehicle ownership model to a transportation subscriber model could expand the revenue opportunities for the potential "tollkeepers" for the monetization of content and data by "nearly an order of magnitude." Looking at U.S. technology leaders Facebook (FB) and Apple (AAPL), which are both valued on their installed base/subscriber models, can "offer valuable clues" regarding the opportunity for General Motors (GM) and other auto OEMs, said Jonas. Viewing the OEMs though the lens of a subscription model, which should be less cyclical and potentially less capital intensive over time than the current auto model, is relevant to analyzing auto stocks, according to Jonas, who adds that it is still too early to call a winner or loser in "Auto 2.0." Other publicly traded legacy automakers include Fiat Chrysler (FCAU), Ford (F), Honda (HMC), Nissan (NSANY), Toyota (TM), Volkswagen (VLKAY) and Daimler (DDAIF).
11/23/18
JEFF
11/23/18
UPGRADE
JEFF
Buy
Renault upgraded to Buy from Hold at Jefferies
Jefferies analyst Philippe Jean Houchois upgraded Renault (RNLSY) to Buy with a price target of EUR 78. The analyst sees the most likely outcome after Carlos Ghosn's arrest as being a re-balancing of the alliance between Renault and Nissan (NSANY) with Renault reducing its stake to possibly as low as 15%. Lowering its Nissan would help reduce the valuation discount and enable Renault to redeploy capital organically or in acquisitions, Houchois tells investors in a research note.
11/23/18
MACQ
11/23/18
DOWNGRADE
MACQ
Neutral
Nissan downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Janet Lewis downgraded Nissan to Neutral an lowered her price target for the shares to 990 yen from 1,350 yen.
FCAU Fiat Chrysler
$15.34

0.16 (1.05%)

10/22/18
JEFF
10/22/18
NO CHANGE
Target $21
JEFF
Buy
Fiat Chrysler sale of Magneti could bring special dividend, says Jefferies
In a research note titled "Best-in-Class Value Creation Continues," Jefferies analyst Philippe Houchois says Fiat Chrysler's sale of Magneti Marelli to Calsonic Kansei for EUR 6.2B met the high end of market expectations. This could give rise to a special dividend of EUR $2B, Houchois tells investors in a research note. Further, the analyst believes the sale also "materially de-risks" Fiat's balance sheet ahead of planned reinvestment in emissions compliance. He keeps a Buy rating on the shares with a $21 price target.
10/26/18
HSBC
10/26/18
DOWNGRADE
HSBC
Hold
Fiat Chrysler downgraded to Hold from Buy at HSBC
10/29/18
SPHN
10/29/18
NO CHANGE
SPHN
Equal Weight
Stephens sees positive take-aways from Auto Finance Summit for Ally Financial
After having attended the Auto Finance Summit in Las Vegas last week, Stephens analyst Vincent Caintic said he is a bit more positive in the near-term on Ally Financial (ALLY), citing the combination of their "timely pivot" to used cars combined with strong dealer relationships that he sees helping them take market share. The analyst added that he thinks America's Car-Mart (CRMT) should benefit, like Ally, from the affordability issue facing consumers. He also believes Santander Consumer (SC) should get bought by Fiat Chrysler (FCAU), but Caintic noted that he heard various opinions at the industry event on the merits of Santander versus another subprime lender. Caintic has Equal Weight ratings on Ally, America's Car-Mart and Santander Consumer.
11/05/18
SOCG
11/05/18
UPGRADE
SOCG
Buy
Fiat Chrysler upgraded to Buy from Hold at Societe Generale
DDAIF Daimler AG
$0.00

(0.00%)

01/08/19
JEFF
01/08/19
DOWNGRADE
JEFF
Hold
BMW downgraded to Hold from Buy at Jefferies
Jefferies anlayst Philippe Houchois downgraded BMW to Hold with a reduced price target of EUR 78. The years of BMW "repeatedly shaming" Daimler (DDAIF) with better margins and free cash flow appear to have ended, Houchois tells investors in a research note. The analyst no longer sees enough upside in BMW shares to warrant a Buy rating.
11/15/18
SBSH
11/15/18
DOWNGRADE
SBSH
Sell
Daimler AG downgraded to Sell from Neutral at Citi (yesterday)
Citi analyst Angus Tweedie yesterday afternoon downgraded Daimler AG to Sell with a price target of EUR 48 after taking over coverage of the name. The analyst is concerned that Daimler will "need to reset expectations once-again" in 2019 as the new management team looks to address the challenges the business model faces and deal with historically inflated expectations.
10/24/18
BOFA
10/24/18
UPGRADE
BOFA
Buy
Daimler AG upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analsyt Fraser Hill upgraded Daimler AG to Buy from Neutral citing valuation.
10/15/18
UBSW
10/15/18
DOWNGRADE
UBSW
Neutral
Daimler AG downgraded to Neutral from Buy at UBS

TODAY'S FREE FLY STORIES

ETFC

E-Trade

$47.45

0.88 (1.89%)

17:33
02/17/19
02/17
17:33
02/17/19
17:33
Conference/Events
E-Trade to hold Education Day »

Education Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

PFE

Pfizer

$42.41

0.45 (1.07%)

12:56
02/17/19
02/17
12:56
02/17/19
12:56
Hot Stocks
Pfizer, EMD Serono announce publication of Phase 3 data for BAVENCIO plus INLYTA »

Merck KGaA, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

MRK

Merck

$79.84

0.9 (1.14%)

, PFE

Pfizer

$42.41

0.45 (1.07%)

12:48
02/17/19
02/17
12:48
02/17/19
12:48
Hot Stocks
Merck presents results from Phase 3 KEYNOTE-426 study »

Merck (MRK) announced…

MRK

Merck

$79.84

0.9 (1.14%)

PFE

Pfizer

$42.41

0.45 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Apr

  • 18

    May

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

12:42
02/17/19
02/17
12:42
02/17/19
12:42
Hot Stocks
Aveo Pharmaceuticals presents TIVO-3 trial topline results »

Aveo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDM

Aradigm

$0.00

(0.00%)

12:34
02/17/19
02/17
12:34
02/17/19
12:34
Hot Stocks
Aradigm announces plans for reorganization under Chapter 11 »

Aradigm has filed for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.